| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A05715709 |
| PharmacoGx | BRD-A05715709 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC003002.4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | AC004076.7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AC004754.3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | AC007192.4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | AC008810.1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | AC010184.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | AC010642.1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | AC010731.4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AC011380.1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
